We also dissect the mechanism by which NELFE LLPS with the chromatin modulator, SMARCB1, to enhance Pol II pausing of pro-apoptotic genes, while distinctly enhancing chromatin accessibility of pro-survival genes in HCC. This evidence concerns the gene SMARCB1 and hepatocellular carcinoma.